DE69909781D1 - Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs - Google Patents

Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs

Info

Publication number
DE69909781D1
DE69909781D1 DE69909781T DE69909781T DE69909781D1 DE 69909781 D1 DE69909781 D1 DE 69909781D1 DE 69909781 T DE69909781 T DE 69909781T DE 69909781 T DE69909781 T DE 69909781T DE 69909781 D1 DE69909781 D1 DE 69909781D1
Authority
DE
Germany
Prior art keywords
topotecan
treating
composition containing
preventing cancer
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69909781T
Other languages
English (en)
Other versions
DE69909781T2 (de
Inventor
K Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22199389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69909781(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of DE69909781D1 publication Critical patent/DE69909781D1/de
Application granted granted Critical
Publication of DE69909781T2 publication Critical patent/DE69909781T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE69909781T 1998-05-21 1999-05-20 Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs Expired - Lifetime DE69909781T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8656098P 1998-05-21 1998-05-21
US86560P 1998-05-21
PCT/US1999/011160 WO1999059565A1 (en) 1998-05-21 1999-05-20 Novel compositions

Publications (2)

Publication Number Publication Date
DE69909781D1 true DE69909781D1 (de) 2003-08-28
DE69909781T2 DE69909781T2 (de) 2004-05-27

Family

ID=22199389

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69909781T Expired - Lifetime DE69909781T2 (de) 1998-05-21 1999-05-20 Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs

Country Status (28)

Country Link
US (1) US6582689B1 (de)
EP (1) EP1079818B1 (de)
JP (1) JP4283998B2 (de)
KR (1) KR100624588B1 (de)
CN (1) CN1227027C (de)
AR (1) AR019844A1 (de)
AT (1) ATE245440T1 (de)
AU (1) AU750918B2 (de)
BR (1) BR9910622A (de)
CA (1) CA2328603A1 (de)
CO (1) CO5050337A1 (de)
CZ (1) CZ300496B6 (de)
DE (1) DE69909781T2 (de)
DK (1) DK1079818T3 (de)
ES (1) ES2204164T3 (de)
GC (1) GC0000102A (de)
HK (1) HK1035136A1 (de)
HU (1) HUP0600520A2 (de)
IL (2) IL139733A0 (de)
MY (1) MY123434A (de)
NO (1) NO329195B1 (de)
NZ (1) NZ508115A (de)
PL (1) PL200840B1 (de)
PT (1) PT1079818E (de)
TR (1) TR200003453T2 (de)
TW (1) TWI227136B (de)
WO (1) WO1999059565A1 (de)
ZA (1) ZA200006675B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2251610T3 (es) * 2001-03-08 2006-05-01 Ares Trading S.A. Mutantes de interleuquina-18, su produccion y su uso.
US20050079153A1 (en) * 2002-08-14 2005-04-14 Pfizer Inc. Methods for enhancing immune functions in neonatal mammals by administration of IL-18
WO2004031276A2 (en) * 2002-09-19 2004-04-15 Centocor, Inc. Method of inducing maturation of dendritic cells and uses therefor
ATE526057T1 (de) * 2004-08-20 2011-10-15 Glaxosmithkline Llc Wundheilung durch verabreichung von menschlichem il-18
WO2008033499A2 (en) * 2006-09-14 2008-03-20 The Trustees Of The University Of Pennsylvania Modulation of regulatory t cells by human il-18
AR065803A1 (es) * 2007-03-23 2009-07-01 Smithkline Beecham Corp Uso de un polipeptido de il- 18 humana y un anticuerpo anti- cd para preparar unmedicamento
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
US8168165B2 (en) * 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
TW201506402A (zh) * 2013-08-15 2015-02-16 Tonyar Biotech Inc 自體防潮的檢驗芯片及其製造方法
IL272635B2 (en) * 2017-09-06 2024-02-01 Univ Yale Variants of interleukin-18 and methods of use
WO2022094473A1 (en) 2020-11-02 2022-05-05 Simcha IL-18, Inc. Interleukin-18 variants and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
TW581771B (en) 1994-11-15 2004-04-01 Hayashibara Biochem Lab Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド

Also Published As

Publication number Publication date
KR20010052369A (ko) 2001-06-25
TR200003453T2 (tr) 2001-10-22
CZ300496B6 (cs) 2009-06-03
IL139733A0 (en) 2002-02-10
EP1079818B1 (de) 2003-07-23
ES2204164T3 (es) 2004-04-16
AR019844A1 (es) 2002-03-20
TWI227136B (en) 2005-02-01
IL139733A (en) 2009-06-15
NZ508115A (en) 2003-12-19
DK1079818T3 (da) 2004-04-19
CZ20004321A3 (en) 2001-05-16
AU750918B2 (en) 2002-08-01
MY123434A (en) 2006-05-31
CN1367686A (zh) 2002-09-04
NO329195B1 (no) 2010-09-13
US6582689B1 (en) 2003-06-24
DE69909781T2 (de) 2004-05-27
ZA200006675B (en) 2002-02-27
JP4283998B2 (ja) 2009-06-24
AU4309499A (en) 1999-12-06
CO5050337A1 (es) 2001-06-27
HUP0600520A2 (en) 2006-10-28
EP1079818A4 (de) 2001-12-12
NO20005857D0 (no) 2000-11-20
CN1227027C (zh) 2005-11-16
CA2328603A1 (en) 1999-11-25
JP2003509333A (ja) 2003-03-11
GC0000102A (en) 2005-06-29
BR9910622A (pt) 2001-01-30
HK1035136A1 (en) 2001-11-16
EP1079818A1 (de) 2001-03-07
PL366170A1 (en) 2005-01-24
PT1079818E (pt) 2004-02-27
PL200840B1 (pl) 2009-02-27
ATE245440T1 (de) 2003-08-15
WO1999059565A1 (en) 1999-11-25
NO20005857L (no) 2000-11-21
KR100624588B1 (ko) 2006-09-18

Similar Documents

Publication Publication Date Title
DE69831222D1 (de) Verbindungen zur immundiagnose von prostatakrebs und deren verwendung
ATE477270T1 (de) Verfahren und zusammensetzungen zur prävention und behandlung von anämie
ATE233049T1 (de) Zusammensetzung und verfahren zur kontrolle von schädlichen bio-organismen
ATE267015T1 (de) Verbindungen und verfahren zur behandlung von krebs
DE69928690D1 (de) Zusammensetzung und Verfahren zur Bindung von Hautirritierenden Mitteln.
HK1048949A1 (en) Method and composition for the treatment of scars
DE69518919T2 (de) Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung
IL142906A0 (en) Methods and compositions for treating or preventing peripheral neuropathies
DE69836008D1 (de) Zusammensetzung und behandlungsmittel
DE69811299D1 (de) Organopolysiloxanzusammensetzung zur Oberflächenbehandlung und oberflächenbehandelte EPDM-Artikel
DE59909631D1 (de) Minderung von Resthalogengehalten und Farbzahlverbesserung in Alkoxysilanen oder Alkoxysilan-basierenden Zusammensetzungen
DE69909781D1 (de) Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
DE69631479D1 (de) Durchsichtiges Material zur elektromagnetischen Abschirmung und Herstellungsverfahren
DE69936251D1 (de) Mittel zur vorbeugung und linderung der periodontose
DE69935326D1 (de) Zusammensetzungen enthaltend molybden zur steigerung des proteinanabolismus und der entgiftung
FI965008A (fi) Koostumukset ja menetelmät kasvainten hoitamiseksi
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
IL141426A0 (en) Compositions and methods for the treatment of tumor
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
IL143212A0 (en) Compositions and methods for the treatment of tumor
DE69809304D1 (de) Zusammensetzung zur Asbestbehandlung
DE69726401D1 (de) Komposit magnetmaterial und material zur unterdruckung von elektromagnetischen interferenzen
ATA125094A (de) Verfahren und anlage zur direktreduktion von eisenoxidhältigem material
DE69930603D1 (de) Zusammensetzung zur Wiederherstellung und Stimulierung der Hautbarrierefunktion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition